A founder’s dystopian AI scenario published on Sunday triggered a stock market meltdown on Monday, with major indexes and specific company shares plummeting. The report, “The 2028 Global Intelligence Crisis,” detailed mass white-collar layoffs and a deflationary cascade, sparking investor anxiety already heightened by AI-related selloffs.
Liraglutide still a ‘decent market’ despite Novo’s price moves: Siddharth Mittal, Biocon
Biocon CEO Siddharth Mittal outlines the company’s strategy in the competitive GLP-1 market. Focusing on liraglutide’s launch in the US and Europe, he highlights opportunities